Foundation Medicine (FMI) Tops Q1 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights
May 3, 2016 4:04 PM EDTCAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. (NASDAQ: FMI) today reported financial and operating results for its first quarter ended March 31, 2016. Highlights for the quarter included:
Achieved first quarter revenue of $30.4 million, 57% year-over-year growth; Reported 8,985 clinical tests in the first quarter, 14% year-over-year growth; Grew the FoundationCORE molecular information knowledgebase, now approaching 80,000 patient cases;... MoreFoundation Medicine Announces Commercial Launch of Liquid Biopsy Assay, FoundationACT™
May 3, 2016 4:02 PM EDT-- Blood-based Genomic Profiling Assay Provides New Option for Cancer Patients Who Are Not Candidates for Tissue Biopsy --
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. (NASDAQ: FMI) today announced the launch of FoundationACT (Assay for Circulating Tumor DNA), an analytically validated and accurate blood-based circulating tumor DNA (ctDNA) assay that provides patients and oncologists with a new option for comprehensive genomic profiling when a tissue biopsy is not feasible or when tissue is not available. By analyzing circulating tumor DNA isolated from a patients blood, FoundationACT can identify clinically... More
